Table 1.
Baseline clinical and glycemic characteristics
| All | Type 1 diabetes | Type 2 diabetes | |
|---|---|---|---|
| n | 427 | 268 | 159 |
| Age (years) | 47.6 ± 13.6 | 44.1 ± 12.9 | 56.6 ± 9.4 |
| Sex (% female) | 54 | 52 | 51 |
| Ethnicity (% non-Hispanic whites) | 83 | 93 | 73 |
| Current smokers | 11 | 12 | 9 |
| Insulin treatment | 76 | 100 | 38 |
| Glycemic measures | |||
| HbA1c (%) | 6.8 ± 1.3 | 7.3 ± 1.1 | 6.8 ± 1.1 |
| MPG (mg/dL) | 149.4 ± 39.6 | 162 ± 36 | 149.4 ± 36 |
| Measures of GV | |||
| CGM SD (mg/dL) | 48.6 ± 25.2 | 64.8 ± 16.2 | 39.6 ± 16.2 |
| MAGE (mg/dL) | 86.4 ± 43.2 | 115.2 ± 32.4 | 68.4 ± 27 |
| CONGA4 (mg/dL) | 66.6 ± 28.8 | 88.2 ± 23.4 | 52.2 ± 21.6 |
| SD (mg/dL) | |||
| ≤30 | 61 (14.3) | 9 (3.4) | 52 (32.7) |
| <30–60 | 173 (40.5) | 84 (31.3) | 89 (56) |
| <60–90 | 173 (40.5) | 155 (57.8) | 18 (11.3) |
| >90 | 20 (4.7) | 20 (7.5) | 0 (0) |
Data are means ± SD, %, or n (%).